Molecular mechanisms of the Keap1Nrf2 pathway in stress response and cancer evolution
Advocates suggest it can help repair tissues, from the digestive system to muscles, tendons, and ligaments
Researchers are investigating options like BPC-157, a peptide not yet approved by the FDA, as a potential therapy
People with chronic obstructive pulmonary disease (COPD) experience long-term oxidative damage and inflammation of lung tissue, which causes airways to constrict, leading to shortness of breath and coughing
But the science on this peptide is lacking (to put it lightly), so we dont know for sure
Several promising compounds have failed in clinical trials due to a range of challenges, including inadequate disease models, late intervention timing, insufficient biomarker validation, and difficulty in distinguishing symptomatic from neuroprotective effects